23andMe Offers 23andMe+

23andMe is offering current 23andMe health service customers in the U.S. 23andMe+, a new annual membership. This membership provides customers with exclusive access to genetic reports, as well as new reports and features as they become available throughout the year.

Priced at $29/year, 23andMe+ will offer existing customers instant access to 10+ exclusive reports and features, including the following:

Pharmacogenetics reports: Discover how your DNA may impact the way your body processes certain medications with three new Pharmacogenetics reports. It includes a Medicine Cabinet feature. Type in your medication’s name to see if it is included in your Pharmacogenetics reports.

Heart Health Reports: Learn how genetics may influence your likelihood of developing certain heart-related conditions like high blood pressure and atrial fibrillation.

Migraine Report (powered by 23andMe Research): See if your genetics can increase your likelihood of experiencing migraine headaches and how to avoid certain triggers.

Obstructive Sleep Apnea report (powered by 23andMe Research): Learn if you have a greater chance of developing the condition based on your genetics and, if so, how you can take action.

Enhanced Ancestry Features: Advanced filtering of DNA relatives and access to up to 3,500 more DNA relatives.

Ongoing new reports and features: Get even more personalized genetic reports and more actionable insights throughout the calendar year.

In the coming months, new customers will also be able to join 23andMe+ when they purchase 23andMe’s health service. With more genetic reports, more health insights, and more features, 23andMe hopes that 23andMe+ gives individuals the choice to help them discover even more about themselves.

23andMe points out that the PGS report results should be confirmed in a clinical setting with independent genetic testing before taking any medical action. Do not use the results to start, stop, or change any course of treatment. The PGS test is not a substitute for visits to a healthcare professional.

Related Articles at FamilyTree.com:

23andMe Explains Your Privacy Protections

23andMe Announced Insights from Lupus Research

23andMe and GSK Start Clinical Trial

< Return To Blog

Leave a Reply

Your email address will not be published.